Jefferies Financial Group Inc. Makes New Investment in Omada Health, Inc. $OMDA

by · The Cerbat Gem

Jefferies Financial Group Inc. acquired a new position in Omada Health, Inc. (NASDAQ:OMDA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,073,991 shares of the company’s stock, valued at approximately $16,948,000.

Several other institutional investors and hedge funds have also bought and sold shares of OMDA. Perceptive Advisors LLC purchased a new stake in Omada Health in the second quarter worth about $44,402,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health in the third quarter worth about $30,510,000. BIT Capital GmbH purchased a new stake in Omada Health in the third quarter worth about $13,639,000. Vanguard Group Inc. lifted its holdings in Omada Health by 642.8% in the third quarter. Vanguard Group Inc. now owns 482,790 shares of the company’s stock worth $10,674,000 after buying an additional 417,790 shares during the period. Finally, Schroder Investment Management Group purchased a new stake in Omada Health in the third quarter worth about $4,440,000.

Insider Buying and Selling

In related news, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer directly owned 117,598 shares in the company, valued at $1,686,355.32. The trade was a 3.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Steven L. Cook sold 1,884 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the completion of the transaction, the chief financial officer owned 200,512 shares of the company’s stock, valued at approximately $2,795,137.28. The trade was a 0.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 8,776 shares of company stock worth $120,483 in the last three months. Insiders own 6.38% of the company’s stock.

Wall Street Analysts Forecast Growth

OMDA has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their target price on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a report on Thursday, March 12th. Needham & Company LLC reiterated a “buy” rating and set a $28.00 target price on shares of Omada Health in a report on Friday, May 8th. Evercore reiterated an “outperform” rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Wells Fargo & Company lifted their target price on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Finally, Barclays lifted their target price on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Check Out Our Latest Stock Analysis on Omada Health

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $16.51 on Monday. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $28.40. The firm has a market cap of $981.52 million and a P/E ratio of -61.15. The company has a 50 day moving average of $14.14 and a 200 day moving average of $15.12.

Omada Health (NASDAQ:OMDA – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million during the quarter. As a group, equities analysts expect that Omada Health, Inc. will post -0.04 earnings per share for the current fiscal year.

About Omada Health

(Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

See Also

Want to see what other hedge funds are holding OMDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omada Health, Inc. (NASDAQ:OMDA – Free Report).